Sartorius Aktiengesellschaft Stock Today
| SARTF Stock | USD 182.98 9.77 5.07% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Sartorius Aktiengesellscha is trading at 182.98 as of the 24th of December 2024. This is a 5.07 percent down since the beginning of the trading day. The stock's lowest day price was 182.98. Sartorius Aktiengesellscha has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of June 2024 and ending today, the 24th of December 2024. Click here to learn more.
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 34.23 M outstanding shares. More on Sartorius Aktiengesellschaft
Moving together with Sartorius Pink Sheet
Moving against Sartorius Pink Sheet
Sartorius Pink Sheet Highlights
| Chairman | Joachim Kreuzburg |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Sartorius Aktiengesellschaft [SARTF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 29.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Aktiengesellscha's market, we take the total number of its shares issued and multiply it by Sartorius Aktiengesellscha's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sartorius Aktiengesellscha classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 34.23 M outstanding shares.
Sartorius Aktiengesellschaft has accumulated about 264.2 M in cash with 865.81 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.86.
Check Sartorius Aktiengesellscha Probability Of Bankruptcy
Ownership AllocationSartorius Aktiengesellscha shows a total of 34.23 Million outstanding shares. Sartorius Aktiengesellscha has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 84.78 % of Sartorius Aktiengesellscha outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sartorius Ownership Details
Sartorius Aktiengesellscha Risk Profiles
| Mean Deviation | 0.9182 | |||
| Standard Deviation | 2.23 | |||
| Variance | 4.95 | |||
| Risk Adjusted Performance | (0.06) |
Sartorius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sartorius Aktiengesellscha without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Sartorius Aktiengesellscha Corporate Management
| Rene Faber | Member of the Executive Board, Head of the Bioprocess Solutions Division | Profile | |
| Rashid Maqbool | Head USA | Profile | |
| Manfred Werner | Sr Auditing | Profile | |
| John MacKay | Member of the Executive Board, Head of the Lab Products & Services Division | Profile | |
| Patricia Spannagel | Head Goettingen | Profile | |
| Mei Wang | Head China | Profile |
Other Information on Investing in Sartorius Pink Sheet
Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.